Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Bioventus Inc.

    NASDAQ: BVS · Real-Time Price · USD
    6.53
    -0.07 (-1.06%)
    At close: Jun 17, 2025, 1:49 PM

    Bioventus Statistics

    Share Statistics

    Bioventus has 66.36M shares outstanding. The number of shares has increased by 3.65% in one year.

    Shares Outstanding

    n/a
    		 66.36M

    Shares Change (YoY)

    n/a
    		 3.65%

    Shares Change (QoQ)

    n/a
    		 1.21%

    Owned by Institutions (%)

    n/a
    		 69.74%

    Shares Floating

    n/a
    		 45.07M

    Failed to Deliver (FTD) Shares

    n/a
    		 50

    FTD / Avg. Volume

    n/a
    		 0.01%

    Short Selling Information

    The latest short interest is 1.17M, so 1.77% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 1.17M

    Short % of Shares Out

    n/a
    		 1.77%

    Short % of Float

    n/a
    		 4.64%

    Short Ratio (days to cover)

    n/a
    		 3.48

    Valuation Ratios

    The PE ratio is -20.46 and the forward PE ratio is 7.44. Bioventus's PEG ratio is 0.29.

    PE Ratio

    n/a
    		 -20.46

    Forward PE

    n/a
    		 7.44

    PS Ratio

    n/a
    		 1.2

    Forward PS

    n/a
    		 0.7

    PB Ratio

    n/a
    		 4.64

    P/FCF Ratio

    n/a
    		 18.16

    PEG Ratio

    n/a
    		 0.29
    Financial Ratio History

    Enterprise Valuation

    Currently the Enterprise Value (EV) is not available for Bioventus.

    EV / Sales

    n/a
    		 n/a

    EV / EBITDA

    n/a
    		 n/a

    EV / EBIT

    n/a
    		 n/a

    EV / FCF

    n/a
    		 n/a

    Financial Position

    The company has a current ratio of 1.31, with a Debt / Equity ratio of 2.27.

    Current Ratio

    n/a
    		 1.31

    Quick Ratio

    n/a
    		 0.87

    Debt / Equity

    n/a
    		 2.27

    Debt / EBITDA

    n/a
    		 -6.77

    Debt / FCF

    n/a
    		 8.88

    Interest Coverage

    n/a
    		 -0.31

    Financial Efficiency

    Return on Equity is n/a and Return on Invested Capital is n/a.

    Return on Equity

    n/a
    		 n/a

    Return on Assets

    n/a
    		 n/a

    Return on Invested Capital

    n/a
    		 n/a

    Revenue Per Employee

    n/a
    		 $616,430.11

    Profits Per Employee

    n/a
    		 $-36,066.67

    Employee Count

    n/a
    		 930

    Asset Turnover

    n/a
    		 0.79

    Inventory Turnover

    n/a
    		 2

    Taxes

    Income Tax

    n/a
    		 -5.29M

    Effective Tax Rate

    n/a
    		 10.77%

    Stock Price Statistics

    The stock price has increased by 10.61% in the last 52 weeks. The beta is 0.85, so Bioventus's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.85

    52-Week Price Change

    n/a
    		 10.61%

    50-Day Moving Average

    n/a
    		 7.05

    200-Day Moving Average

    n/a
    		 9.93

    Relative Strength Index (RSI)

    n/a
    		 43.84

    Average Volume (20 Days)

    n/a
    		 385,701

    Income Statement

    In the last 12 months, Bioventus had revenue of 573.28M and earned -33.54M in profits. Earnings per share was -0.75.

    Revenue

    n/a
    		 573.28M

    Gross Profit

    n/a
    		 388.23M

    Operating Income

    n/a
    		 -11.98M

    Net Income

    n/a
    		 -33.54M

    EBITDA

    n/a
    		 -49.55M

    EBIT

    n/a
    		 -10.33M

    Earnings Per Share (EPS)

    n/a
    		 -0.75
    Full Income Statement

    Balance Sheet

    The company has 41.58M in cash and 335.63M in debt, giving a net cash position of -294.05M.

    Cash & Cash Equivalents

    n/a
    		 41.58M

    Total Debt

    n/a
    		 335.63M

    Net Cash

    n/a
    		 -294.05M

    Retained Earnings

    n/a
    		 -355.08M

    Total Assets

    n/a
    		 691.41M

    Working Capital

    n/a
    		 74.62M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 38.8M and capital expenditures -1.01M, giving a free cash flow of 37.79M.

    Operating Cash Flow

    n/a
    		 38.8M

    Capital Expenditures

    n/a
    		 -1.01M

    Free Cash Flow

    n/a
    		 37.79M

    FCF Per Share

    n/a
    		 0.58
    Full Cash Flow Statement

    Margins

    Gross margin is 67.72%, with operating and profit margins of -2.09% and -5.85%.

    Gross Margin

    n/a
    		 67.72%

    Operating Margin

    n/a
    		 -2.09%

    Pretax Margin

    n/a
    		 -8.57%

    Profit Margin

    n/a
    		 -5.85%

    EBITDA Margin

    n/a
    		 -8.64%

    EBIT Margin

    n/a
    		 -2.09%

    FCF Margin

    n/a
    		 6.59%

    Dividends & Yields

    BVS does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 n/a

    FCF Yield

    n/a
    		 n/a
    Dividend Details

    Analyst Forecast

    The average price target for BVS is $15, which is 128.3% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $15

    Price Target Difference

    n/a
    		 128.3%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 3
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Scores

    Altman Z-Score

    n/a
    		 0.68

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist